✦ LIBER ✦

P-225 XPD and RRM1 gene polymorphisms predict gemcitabine (gem)/cisplatin (cis)/docetaxel (doc) outcome in stage III non-small-cell lung cancer (NSCLC): a genetic analysis of the Spanish Lung Cancer Group phase II trial 9901

✍ Scribed by Sarries, Carme; Garrido, Pilar; Nun˜ez, Laura; Roig, Barbara; Ramirez, Jose Luis; Isla, Dolores; Astudillo, Julio; Sanchez, Jose Javier; Taron, Miquel; Rosell, Rafael

Book ID: 118571926
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 178 KB
Volume: 41
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(03)92194-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-224 XPD polymorphisms in cisplatin (ci

P-224 XPD polymorphisms in cisplatin (cis)/vinorelbine (vrb)-treated stage IV non-small-cell lung cancer (NSCLC) patients (p): genetic analysis of a Spanish Lung Cancer Group phase II trial

✍ Vin˜olas, Nuria; Roig, Barbara; Reguart, Noemi; Provencio, Mariano; Cardenal, Fe 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 178 KB

P-220 Polymorphisms in DNA repair genes

P-220 Polymorphisms in DNA repair genes and survival in cisplatin (cis)/docetaxel (doc)-treated stage IV non-small-cell lung cancer (NSCLC) patients (p): a Spanish Lung Cancer Group phase II trial

✍ Isla, Dolores; Queralt, Cristina; Alonso, Guillermo; Domine, Manuel; Barcelo, Ra 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 174 KB

P-203 SLCG 9901: phase II trial with cis

P-203 SLCG 9901: phase II trial with cisplatin (cis), gemcitabine (gem) and docetaxel (doc) as neoadjuvant treatment in stage IIIA N2 and T4N0-1 non-small cell lung cancer (NSCLC) patients

✍ Garrido, Pilar; Barceló, Ramón; Artal, Angel; Terrasa, Josefa; Massuti, Bartomeu 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 162 KB

O-033 Docetaxel (DOC), cisplatin (CIS) a

O-033 Docetaxel (DOC), cisplatin (CIS) and gemcitabine (GEM) asneoadjuvant treatment in stage IIIAN2 and T4N0-1 non-small cell lung cancer (NSCLC) patients (P). final results of SLCG phase II trial 9901

✍ Garrido, P.; Rosell, R.; Torres, A.; González Larriba, J.; Provencio, M.; Isla, 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 150 KB

O-089 ERCC1 mRNA-based randomized phase

O-089 ERCC1 mRNA-based randomized phase III trial of docetaxel (doc) doublets with cisplatin (cis) or gemcitabine (gem) in stage IV non-small-cell lung cancer (NSCLC) patients (p)

✍ Cobo, M.; Isla, D.; Sánchez, J.; Massuti, B.; Montes, A.; Paz-Ares, L.; Múñoz, M 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 131 KB

P-478 CPT-11-docetaxel in untreated pati

P-478 CPT-11-docetaxel in untreated patients with advanced non small cell lung cancer (NSCLC). A phase II study of the Spanish Lung Cancer Group (SLCG). Correlation with the single nucleotide polymorphisms (SNPs) of UGT1A1, XPD2 and XRCC1

✍ Domine, M.; Isla, D.; Cobo, M.; Camps, C.; Batista, N.; Almenarez, J.; Medina, B 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 149 KB